Influence of method of preparation on physico-chemical properties and in-vitro drug release profile of nimodipine-cyclodextrin inclusion complexes: A comparative study

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 1, 2010, Pages 71-81

  Patil, J S ^a   Pandya, N R ^a   Marapur, S C ^a   Shiralashetti, S S ^b  

^a BLDE UNIVERSITY   (India)

^b KARNATAKA COLLEGE OF PHARMACY   (India)

Author keywords

CD; Dissolution rate; HP CD; Inclusion complex; Nimodipine; Spray drying

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; NIMODIPINE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; IN VITRO STUDY; PHYSICAL CHEMISTRY; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY DIFFRACTION;

EID: 77953445307     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ramoska EA, Spiller HA, Myers A. Calcium Channel Blocker Toxicity. Ann Emerg Med. 1990; 19 (6): 649-653.
2. Steele RM, Schuna AA, Schreiber R T. Calcium Antagonist-Induced Gingival Hyperplasia. Ann Intern Med.1994; 120 (8): 663-664.
3. Szetjli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev. 1998; 98: 1743-1753.
4. Peters J, Neeskens P, Tollenaere JP, Van P, Remoortere, Brewster ME. Characterization of the interaction of 2-hydroxypropyl β -cyclodextrin with itraconazole at pH 2, 4, and 7, J Pharm Sci 2002; 91: 1414-1422.
5. Al-Marzouqui AH, Shehatta L, Jobe B, Dowaider A. Phase solubility and inclusion complex of itraconazole with β-cyclodextrin using supercritical carbon dioxide. J Pharm Sci 2006; 95:292-304.
6. Wen X, Liu Z, Zhu T. Mass spectrometry and molecular modeling studies on the inclusion complexes between α, β-cyclodextrins and simvastatin. Chem Phys Lett 2005; 405:114-117.
7. Higuchi T, Connors, KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965; 4: 117-212.
8. Doijad RC, Kanakal MM, Manvi FV. Effects of processing variables on dissolution and solubility of piroxicam:Hydroxypropyl β-cyclodextrin inclusion complex. Indian J Pharm Sci 2007; 69 (2): 323-326.
9. Michael J. Spray drying and spray congealing of pharmaceuticals. Encyclopedia of pharmaceutical technology, Marcel Dekker INC. 1993; 14: 207-221.
10. Veiga F, Teixeira-Dias JJC, Kedzierewicz F, Sousa A, Maincent P. Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int J Pharm 1996; 129: 63-71.
11. Wei FZ, Xi GC, Pi Wu Li, Cheng L, Qiang Z H. Preparation and Characterization of Carboxymethyl Chitosan and β -cyclodextrin Microspheres by Spray Drying. Dry Tech 2008; 26: 108-115.
12. Seoung WJ, et al,. Preparation and characterization of Simvastatin/hydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2007; 66: 413-421.
13. Patel RP, Patel MM. Physico-chemical characterization and in-vitro dissolution behaviors of Simvastatin β-cyclodextrin inclusion compounds. http://www.drugdeliverytechonline.com/drugdelivery/200705/templates/pageviewer.
14. Moore JW, Flanner H. Mathematical comparison of dissolution profiles. Phar Tech 1996; 20: 64-74.
15. Reppas C, Nicolaides E. Analysis of drug dissolution data, Oral Drug Absorption Prediction and Assessment. J. B. Dressman, H. Ed. Lennernäs, Marcel Dekker, Inc., New York; 2000; 229-254.
16. Peri D, Wyandt CM, Cleary RW, Hickal AH, Jones AB. Inclusion complexes of Tolnaftate with β- Cyclodextrin and hydroxylpropyl-β-cyclodextrin. Drug Dev Ind Pharm 1994; 20: 1401-1410.